Accelerant Holdings (NYSE: ARX), the specialty insurance risk exchange operator that listed on the New York Stock Exchange only in July 2025, has agreed to be taken private by software-focused private equity firm Thoma Bravo in an all-cash transaction valued at more than $4 billion in enterprise value. Under the definitive agreement announced on August 13, 2026, holders of Accelerant Holdings Class A and Class B shares would receive $20.25 per share, a 49% premium to the August 12, 2026 closing price of $13.61. The transaction, expected to close in the first half of 2027, arrived alongside a materially stronger second-quarter result and effectively ends a public run that lasted just over 12 months. The central question is whether the offer captures a business whose operating trajectory was already inflecting, or whether the special committee took the certainty of a premium to a depressed price rather than testing the market longer with an improved earnings profile.
What Thoma Bravo is paying for Accelerant Holdings and how the $20.25 offer compares to recent trading
The headline economics are straightforward. Thoma Bravo would pay $20.25 per share in cash for every outstanding Class A and Class B share of Accelerant Holdings, producing an enterprise value of more than $4 billion and an implied equity value in the same range given Accelerant Holdings’ roughly 217.19 million shares outstanding. The 49% premium is measured against the August 12, 2026 close of $13.61, and Accelerant Holdings shares closed at $19.52 on August 13 following the announcement, a session-on-session gain of 43.42% on volume of 69.1 million shares versus a three-month average of approximately 3.1 million. That gap between $19.52 and the $20.25 offer price reflects the standard arbitrage discount for time-value and regulatory-approval risk over the roughly nine to twelve months remaining until expected completion.
The premium looks large against the reference close but less impressive against Accelerant Holdings’ prior trading history. The company priced its initial public offering at $21 per share on July 24, 2025, raised approximately $724 million on an upsized deal of 34.46 million shares, and traded as high as $30.05 in August 2025. For most of 2026, the stock sat below $15, and it touched a 52-week low near $9.18 to $9.20 before recovering into the mid-teens ahead of the second-quarter release. The offer therefore delivers a small premium to the IPO price and a clean exit for later buyers, but leaves early public-market investors from the August 2025 highs still meaningfully below their entry levels even after the takeout.
Why Accelerant Holdings’ second-quarter results changed the context of the take-private offer
The transaction landed on the same morning as Accelerant Holdings’ second-quarter 2026 results, and the numbers reshaped the interpretive frame. Total revenue reached $356.9 million against $219.1 million in the prior-year period, a 63% year-on-year increase. Net income rose to $80.0 million from $13.1 million. Adjusted EBITDA came in at $93.1 million on a margin of 31%. Exchange Written Premium, the measure most closely tied to Accelerant Holdings’ Exchange Services segment, grew 23% year-on-year to $1,322.3 million, with trailing-twelve-months premiums of $4.6 billion. Gross margin remained near 70% at the group level, consistent with a platform-plus-fronting model where the marketplace layer scales without proportional cost.
The operating quality of the print materially exceeded expectations, and one intra-day trading commentary flagged an earnings surprise of roughly 100% against consensus. That creates a specific tension with the deal price. The reference share price used to calculate the 49% premium, $13.61, reflected the market’s view of Accelerant Holdings before the second-quarter numbers were disclosed. The offer was negotiated over a period in which the special committee had visibility into the results; public shareholders did not. The question of whether the eventual close would look as attractive against a share price re-rated for the second-quarter beat is one the process now removes from the table.
How Altamont Capital Partners’ 82% voting agreement effectively locks the transaction outcome
Two governance features together make the shareholder vote essentially procedural rather than contested. Altamont Capital Partners, described in the announcement materials as Accelerant Holdings’ largest investor and holder of approximately 82% of the outstanding voting rights, has entered into a voting agreement to support the transaction. Altamont Capital Partners and the company’s founders also plan to retain equity ownership alongside Thoma Bravo in the private-company structure, meaning the largest shareholder is a roll-over participant rather than a full cash-exit seller.
The Accelerant Holdings board formed a special committee composed of independent and disinterested directors to evaluate the offer, advised separately by Houlihan Lokey. The special committee unanimously recommended the transaction, and the full board then unanimously approved it. Morgan Stanley acted as exclusive financial advisor to the board. Thoma Bravo was advised by BMO Capital Markets and Wells Fargo. Legal advisors span Paul Hastings, Sidley Austin, Maples Group, Conyers Dill & Pearman, Goodwin Procter, Skadden (led by Elena Coyle for Thoma Bravo), Walkers and Ropes & Gray. With 82% of voting rights already committed and an independent-committee recommendation in hand, execution risk shifts almost entirely from the shareholder vote toward regulatory approvals and insurance-specific consents.
What Thoma Bravo’s existing insurance technology footprint tells you about the Accelerant thesis
Thoma Bravo is described in the announcement as the world’s largest software-focused investment firm, with more than $172 billion in assets under management as of March 31, 2026 and approximately 590 companies acquired or invested in over the past two decades representing more than $320 billion in aggregate value. That software framing matters because Accelerant Holdings has consistently positioned its Accelerant Risk Exchange as a data and analytics platform rather than a balance-sheet insurance company, with fee revenue for sourcing, managing and monitoring specialty risk on behalf of member underwriters and risk capital partners.
Thoma Bravo has a visible insurance technology track record supporting a platform-consolidation thesis. Its portfolio has included Majesco, which provides cloud-based policy, billing, claims and underwriting software to carriers. In May 2025, Thoma Bravo-backed Nearmap agreed to acquire property claims analytics business itel from GTCR at a reported enterprise value exceeding $1.3 billion, subsequently framed by trade press as part of an $8 billion combined platform build-out at the intersection of aerial imagery and insurance claims processing. Matt LoSardo, a principal at Thoma Bravo, was quoted in wire coverage describing Accelerant Holdings’ position in specialty insurance as rare. Accelerant Holdings therefore slots into a live insurance-adjacent portfolio, and Thoma Bravo’s typical playbook of operational efficiency, tuck-in acquisitions and software-driven margin expansion translates directly to a marketplace whose economics are already software-like at the platform layer.
Why the special committee accepted a premium to a depressed price rather than testing the market longer
The deal offers a stated 49% premium and a clean price above the analyst consensus 12-month target of approximately $19.11 that had prevailed heading into the announcement. It also arrives after a sustained period in which the share price sat well below both the July 2025 IPO price of $21 and the August 2025 peak above $30. RBC analyst Rowland Mayor, quoted in wire coverage, characterised the outcome as reasonable given what he described as extreme market volatility and a disconnect between the company’s fundamentals and the share price. Morgan Stanley had lowered its price target to $14 from $16 with an Equal Weight rating ahead of the announcement, and William Blair was reported to have downgraded the stock to Hold, suggesting that public-market sell-side sentiment had not yet caught up to the second-quarter operating inflection.
Business News Today makes no assessment of whether the special committee could have secured a higher price by extending the process. Two forces cut in opposite directions. On one side, running a longer competitive process might have surfaced additional bidders and captured more of the second-quarter beat in the reference price; on the other, Altamont Capital Partners’ willingness to roll over its stake, the structural difficulty of finding buyers able to consume a specialty insurance platform at this scale, and the risk of losing Thoma Bravo’s committed all-cash equity funding argue for taking the certainty on offer. The special committee’s own view is captured in the unanimous recommendation.
What the Accelerant Risk Exchange platform actually does for specialty insurance sellers and capital partners
The Accelerant Risk Exchange is a two-sided marketplace connecting specialty insurance underwriters, described in Accelerant Holdings’ filings as Sellers, with risk capital providers, described as Buyers. The Exchange Services segment monetises the platform through fees for sourcing, managing and monitoring specialty insurance business, and offers technology, data ingestion and agency operations to member underwriters. Alongside that platform layer, Accelerant Holdings operates MGA Operations and Underwriting segments that write specialty premium directly, primarily focused on small-to-medium commercial clients across the United States, Europe, Canada and the United Kingdom.
The Q2 2026 print illustrated the model’s operating leverage. Exchange Written Premium of $1,322.3 million growing at 23% year-on-year, combined with segment fees, suggests that platform economics are increasingly setting the shape of group profitability rather than pure underwriting outcomes. That is consistent with the strategic case Jeff Radke, Accelerant Holdings’ Chairman and Chief Executive Officer, articulated in the deal statement, describing the ambition to build the platform into the rails on which specialty insurance runs. Under private ownership, Radke argued, Thoma Bravo’s technology and software capital would let Accelerant Holdings invest more aggressively in that platform without quarterly public-market scrutiny.
How the 6% per annum ticking fee protects Accelerant Holdings shareholders against regulatory delay
One structural feature of the merger agreement deserves specific attention. If closing is delayed beyond a specified point by pending insurance regulatory approvals, Accelerant Holdings shareholders would accrue a ticking fee of 6% per annum. Ticking fees compensate a target’s shareholders for the time value of holding until close, and 6% is at the upper end of typical market practice for take-private transactions. The mechanism reflects the reality that insurance-industry deals face jurisdiction-by-jurisdiction change-of-control and Form A filings, and that consolidated approvals across the United States, United Kingdom, European Union and other geographies can stretch timelines materially.
The transaction is not subject to a financing condition; Thoma Bravo has provided an equity commitment to fund the acquisition in full. That removes one of the two conventional risk axes for a take-private deal. The remaining risk axis is regulatory, and the ticking fee is the contractual acknowledgement that regulatory processes for a multi-jurisdictional specialty insurance platform are unlikely to move quickly.
What still needs to happen between the definitive agreement and expected first-half 2027 completion
Between the August 13 announcement and expected completion in the first half of 2027, the required steps include a shareholder vote, insurance-specific regulatory approvals across Accelerant Holdings’ operating jurisdictions, and customary antitrust and change-of-control filings. Given Altamont Capital Partners’ 82% voting commitment, the shareholder vote itself carries limited residual risk. The primary uncertainty concentrates in insurance regulators, particularly in the United States where each state insurance department administers its own Form A filings, and in the United Kingdom, European Union and Cayman Islands where separate consents apply.
Public-market investors have three residual choices to consider. They can accept the offer and tender at $20.25 per share. They can hold to receive the ticking fee accrual if regulatory delays materialise, at the cost of extended exposure to the deal-break risk. Or they can exit into the market at the current spread to offer price, monetising most of the value now and forgoing the residual arbitrage. None of these routes is obviously superior; each depends on the individual holder’s cost basis, tax position and view on the base-rate probability of insurance regulators clearing the transaction on the timeline described.
What are the key numbers and forward catalysts from the Thoma Bravo agreement to acquire Accelerant Holdings
- Thoma Bravo has agreed to acquire Accelerant Holdings for $20.25 per share in cash, an enterprise value of more than $4 billion, a 49% premium to the August 12, 2026 close of $13.61, and a clean price above the pre-announcement analyst consensus target of approximately $19.11.
- The deal arrived alongside Accelerant Holdings’ second-quarter 2026 results showing revenue of $356.9 million (+63% year-on-year), net income of $80.0 million versus $13.1 million, adjusted EBITDA of $93.1 million at a 31% margin, and Exchange Written Premium of $1,322.3 million (+23%) against trailing-twelve-months premiums of $4.6 billion.
- Altamont Capital Partners, which holds approximately 82% of outstanding voting rights, has entered a voting agreement to support the transaction and plans to retain equity alongside Thoma Bravo; Accelerant Holdings’ founders also plan to roll over.
- The Accelerant Holdings board’s special committee, advised by Houlihan Lokey and separate from Morgan Stanley’s role as exclusive financial advisor to the full board, unanimously recommended the deal, which the full board then unanimously approved.
- Thoma Bravo, described as the world’s largest software-focused investment firm with more than $172 billion in assets under management as of March 31, 2026, is not subject to a financing condition; the firm has provided an equity commitment funding the transaction in full.
- The transaction carries a 6% per annum ticking fee that accrues to shareholders if closing is delayed by insurance regulatory approvals, an unusually shareholder-friendly protection sized at the upper end of typical market practice.
- Expected close is the first half of 2027, subject to shareholder approval and customary regulatory clearances including insurance-specific approvals across the United States, United Kingdom, European Union and Cayman Islands.
- Accelerant Holdings listed on the New York Stock Exchange only on July 24, 2025 at an IPO price of $21 per share, briefly traded above $30 in August 2025, and sat below $15 for most of 2026 before touching lows near $9.18 to $9.20; the take-private ends a public run of just over 12 months.
- Thoma Bravo’s insurance technology footprint, including Majesco and the Nearmap-itel property intelligence platform reportedly worth over $1.3 billion in enterprise value, points to a platform-consolidation thesis under which Accelerant Risk Exchange would receive private-market investment in software, data and adjacent tuck-in acquisitions.
- The thesis strengthens if insurance regulators clear the transaction within the disclosed timeline and Accelerant Holdings executes on the Exchange Services growth trajectory implied by the Q2 2026 print; it weakens if regulatory delays extend the close materially beyond first-half 2027 or if the Q2 operating momentum in premium growth and margin expansion fails to sustain into the second half of 2026.
Discover more from Business-News-Today.com
Subscribe to get the latest posts sent to your email.
